Australia: Blackstone to acquire Phase 1 clinical trials provider Nucleus Network

Private equity funds managed by Blackstone have agreed to acquire Nucleus Network, Australia’s largest Phase 1 clinical trials provider. Nucleus Network is the only Phase 1 specialist globally with facilities in the USA and Australia with facilities in Melbourne, Brisbane and Minneapolis. Australia is a leading destination for clinical trials, according to Blackstone. The country’s…

You must be a HMI Subscriber to view this content.

Subscribe Now »